| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000261512.2 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.037025671 |
Resistant |
| ENSG00000261512.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.012894262 |
Resistant |
| ENSG00000261512.2 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.046491244 |
Sensitive |
